Preclinical mouse solid tumour models: status quo, challenges and perspectives.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29077691.
- Also identified by DOI 10.1038/nrc.2017.92.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oncology research in humans is limited to analytical and observational studies for obvious ethical reasons, with therapy-focused clinical trials being the one exception to this rule. Preclinical mouse tumour models therefore serve as an indispensable intermediate experimental model system bridging more reductionist in vitro research with human studies. Based on a systematic survey of preclinical mouse tumour studies published in eight scientific journals in 2016, this Analysis provides an overview of how contemporary preclinical mouse tumour biology research is pursued. It thereby identifies some of the most important challenges in this field and discusses potential ways in which preclinical mouse tumour models could be improved for better relevance, reproducibility and translatability.
Medical subject headings
- Disease Models, Animal
- Neoplasms
- Translational Research, Biomedical